Selected research
Market Outlook & Growth Opportunities
Global Bifunctional Epoxide Hydrolase 2 Market Outlook and Growth Opportunities 2026
Market perspective
The global Bifunctional Epoxide Hydrolase 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Bifunctional Epoxide Hydrolase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Bifunctional Epoxide Hydrolase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Bifunctional Epoxide Hydrolase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Bifunctional Epoxide Hydrolase 2 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Bifunctional Epoxide Hydrolase 2 market include Sumitomo Dainippon Pharma Co., Ltd., GlaxoSmithKline Plc, Toray Industries, Inc. and Sphaera Pharma Pvt. Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Bifunctional Epoxide Hydrolase 2 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Bifunctional Epoxide Hydrolase 2 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Bifunctional Epoxide Hydrolase 2 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bifunctional Epoxide Hydrolase 2 market size, projected growth trends, production technologies, key applications, and end-use industries.
Bifunctional Epoxide Hydrolase 2 Segment by Company
Sumitomo Dainippon Pharma Co., Ltd.
GlaxoSmithKline Plc
Toray Industries, Inc.
Sphaera Pharma Pvt. Ltd.
Bifunctional Epoxide Hydrolase 2 Segment by Type
EC-5026
GSK-2256294
RB-394
Others
Bifunctional Epoxide Hydrolase 2 Segment by Application
Kidney Cancer
Liver Cancer
Lung Cancer
Others
Bifunctional Epoxide Hydrolase 2 Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Bifunctional Epoxide Hydrolase 2 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Bifunctional Epoxide Hydrolase 2 market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Bifunctional Epoxide Hydrolase 2 significant trends, drivers, influence factors in global and regions.
6. To analyze Bifunctional Epoxide Hydrolase 2 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bifunctional Epoxide Hydrolase 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bifunctional Epoxide Hydrolase 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bifunctional Epoxide Hydrolase 2.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Bifunctional Epoxide Hydrolase 2 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bifunctional Epoxide Hydrolase 2 industry.
Chapter 3: Detailed analysis of Bifunctional Epoxide Hydrolase 2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Bifunctional Epoxide Hydrolase 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Bifunctional Epoxide Hydrolase 2 in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- EC-5026
- GSK-2256294
- RB-394
- Others
Applications
- Kidney Cancer
- Liver Cancer
- Lung Cancer
- Others
Companies covered
- Sumitomo Dainippon Pharma Co., Ltd.
- GlaxoSmithKline Plc
- Toray Industries, Inc.
- Sphaera Pharma Pvt. Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Bifunctional Epoxide Hydrolase 2 Sales Value (2021-2032)
- 1.2.2 Global Bifunctional Epoxide Hydrolase 2 Sales Volume (2021-2032)
- 1.2.3 Global Bifunctional Epoxide Hydrolase 2 Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Bifunctional Epoxide Hydrolase 2 Market Dynamics
- 2.1 Bifunctional Epoxide Hydrolase 2 Industry Trends
- 2.2 Bifunctional Epoxide Hydrolase 2 Industry Drivers
- 2.3 Bifunctional Epoxide Hydrolase 2 Industry Opportunities and Challenges
- 2.4 Bifunctional Epoxide Hydrolase 2 Industry Restraints
3 Bifunctional Epoxide Hydrolase 2 Market by Company
- 3.1 Global Bifunctional Epoxide Hydrolase 2 Company Revenue Ranking in 2025
- 3.2 Global Bifunctional Epoxide Hydrolase 2 Revenue by Company (2021-2026)
- 3.3 Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Company (2021-2026)
- 3.4 Global Bifunctional Epoxide Hydrolase 2 Average Price by Company (2021-2026)
- 3.5 Global Bifunctional Epoxide Hydrolase 2 Company Ranking (2024-2026)
- 3.6 Global Bifunctional Epoxide Hydrolase 2 Company Manufacturing Base and Headquarters
- 3.7 Global Bifunctional Epoxide Hydrolase 2 Company Product Type and Application
- 3.8 Global Bifunctional Epoxide Hydrolase 2 Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Bifunctional Epoxide Hydrolase 2 Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Bifunctional Epoxide Hydrolase 2 Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Bifunctional Epoxide Hydrolase 2 Market by Type
- 4.1 Bifunctional Epoxide Hydrolase 2 Type Introduction
- 4.1.1 EC-5026
- 4.1.2 GSK-2256294
- 4.1.3 RB-394
- 4.1.4 Others
- 4.2 Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Type
- 4.2.1 Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Type (2021-2032)
- 4.2.3 Global Bifunctional Epoxide Hydrolase 2 Sales Volume Share by Type (2021-2032)
- 4.3 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Type
- 4.3.1 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Type (2021-2032)
- 4.3.3 Global Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type (2021-2032)
5 Bifunctional Epoxide Hydrolase 2 Market by Application
- 5.1 Bifunctional Epoxide Hydrolase 2 Application Introduction
- 5.1.1 Kidney Cancer
- 5.1.2 Liver Cancer
- 5.1.3 Lung Cancer
- 5.1.4 Others
- 5.2 Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Application
- 5.2.1 Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Application (2021-2032)
- 5.2.3 Global Bifunctional Epoxide Hydrolase 2 Sales Volume Share by Application (2021-2032)
- 5.3 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Application
- 5.3.1 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Application (2021-2032)
- 5.3.3 Global Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application (2021-2032)
6 Bifunctional Epoxide Hydrolase 2 Regional Sales and Value Analysis
- 6.1 Global Bifunctional Epoxide Hydrolase 2 Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Bifunctional Epoxide Hydrolase 2 Sales by Region (2021-2032)
- 6.2.1 Global Bifunctional Epoxide Hydrolase 2 Sales by Region: 2021-2026
- 6.2.2 Global Bifunctional Epoxide Hydrolase 2 Sales by Region (2027-2032)
- 6.3 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Region (2021-2032)
- 6.4.1 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Region: 2021-2026
- 6.4.2 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Region (2027-2032)
- 6.5 Global Bifunctional Epoxide Hydrolase 2 Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Bifunctional Epoxide Hydrolase 2 Sales Value (2021-2032)
- 6.6.2 North America Bifunctional Epoxide Hydrolase 2 Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Bifunctional Epoxide Hydrolase 2 Sales Value (2021-2032)
- 6.7.2 Europe Bifunctional Epoxide Hydrolase 2 Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Bifunctional Epoxide Hydrolase 2 Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Bifunctional Epoxide Hydrolase 2 Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Bifunctional Epoxide Hydrolase 2 Sales Value (2021-2032)
- 6.9.2 South America Bifunctional Epoxide Hydrolase 2 Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Bifunctional Epoxide Hydrolase 2 Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Bifunctional Epoxide Hydrolase 2 Sales Value Share by Country, 2025 VS 2032
7 Bifunctional Epoxide Hydrolase 2 Country-level Sales and Value Analysis
- 7.1 Global Bifunctional Epoxide Hydrolase 2 Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Bifunctional Epoxide Hydrolase 2 Sales by Country (2021-2032)
- 7.3.1 Global Bifunctional Epoxide Hydrolase 2 Sales by Country (2021-2026)
- 7.3.2 Global Bifunctional Epoxide Hydrolase 2 Sales by Country (2027-2032)
- 7.4 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Country (2021-2032)
- 7.4.1 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Country (2021-2026)
- 7.4.2 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.9.2 France Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.16.2 China Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.19.2 India Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Sumitomo Dainippon Pharma Co., Ltd.
- 8.1.1 Sumitomo Dainippon Pharma Co., Ltd. Company Information
- 8.1.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview
- 8.1.3 Sumitomo Dainippon Pharma Co., Ltd. Bifunctional Epoxide Hydrolase 2 Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Sumitomo Dainippon Pharma Co., Ltd. Bifunctional Epoxide Hydrolase 2 Product Portfolio
- 8.1.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Developments
- 8.2 GlaxoSmithKline Plc
- 8.2.1 GlaxoSmithKline Plc Company Information
- 8.2.2 GlaxoSmithKline Plc Business Overview
- 8.2.3 GlaxoSmithKline Plc Bifunctional Epoxide Hydrolase 2 Sales, Value and Gross Margin (2021-2026)
- 8.2.4 GlaxoSmithKline Plc Bifunctional Epoxide Hydrolase 2 Product Portfolio
- 8.2.5 GlaxoSmithKline Plc Recent Developments
- 8.3 Toray Industries, Inc.
- 8.3.1 Toray Industries, Inc. Company Information
- 8.3.2 Toray Industries, Inc. Business Overview
- 8.3.3 Toray Industries, Inc. Bifunctional Epoxide Hydrolase 2 Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Toray Industries, Inc. Bifunctional Epoxide Hydrolase 2 Product Portfolio
- 8.3.5 Toray Industries, Inc. Recent Developments
- 8.4 Sphaera Pharma Pvt. Ltd.
- 8.4.1 Sphaera Pharma Pvt. Ltd. Company Information
- 8.4.2 Sphaera Pharma Pvt. Ltd. Business Overview
- 8.4.3 Sphaera Pharma Pvt. Ltd. Bifunctional Epoxide Hydrolase 2 Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Sphaera Pharma Pvt. Ltd. Bifunctional Epoxide Hydrolase 2 Product Portfolio
- 8.4.5 Sphaera Pharma Pvt. Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Bifunctional Epoxide Hydrolase 2 Value Chain Analysis
- 9.1.1 Bifunctional Epoxide Hydrolase 2 Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Bifunctional Epoxide Hydrolase 2 Sales Mode & Process
- 9.2 Bifunctional Epoxide Hydrolase 2 Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Bifunctional Epoxide Hydrolase 2 Distributors
- 9.2.3 Bifunctional Epoxide Hydrolase 2 Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst